← Insider buys
MAZE

Maze Therapeutics, Inc. · Healthcare

President, R&D & CMO Harold Bernstein sold $435K of Maze Therapeutics, Inc.

Sold$434,743
$26.93Price
16,141Shares
−100%Stake

What MAZE did after the filing

Prices for MAZE after this filing aren't in yet.

Traded Thu, Oct 1. Filed Fri, Oct 2, 4:09 PM ET, after the close. Not investment advice.